Survey Question | % (n) |
---|---|
Compared with the common problems you face in practice, how important would you consider hepatitis C to be? (percent responding more important/important; N = 491) | 67.8 (333) |
Compared with the common medical problems you screen for in practice, how important would you consider screening for HCV to be? (percent responding more important/important; N = 490) | 58.8 (288) |
The extent to which you agree or disagree about whether primary care providers should be doing the following with respect to hepatitis C (percent responding strongly agree/agree; N = 494*) | |
Screening | 87.5 (428) |
Diagnosis | 93.0 (456) |
Treatment with antiviral therapy | 29.6 (144) |
Monitoring and follow-up | 66.9 (327) |
Referral for consultation and comanagement of hepatitis C | 94.9 (463) |
Referral for all hepatitis C management | 50.6 (247) |
How do you assess patients for these concerns (N = 490–494): | |
Intravenous drug use | |
Routinely ask new patients | 53.8 (266) |
Ask patients who give a history of other illicit drug use | 54.0 (267) |
Blood transfusion or solid organ transplant before July 1992 | |
Routinely ask new patients | 28.4 (139) |
Ask patients who have abnormal liver function tests | 42.7 (209) |
Under what circumstances do you order serum ALT levels? (N = 487) | |
Routine screen for new patients | 25.3 (123) |
Patients with other risk factors for hepatitis C | 60.6 (295) |
Patients with a history of hepatitis C | 56.3 (274) |
How often do you order a hepatitis C antibody test? (percent responding always/frequently; N = 494*) | |
Patient history of intravenous drug use | 75.9 (375) |
Patient history of blood transfusion/organ transplant before 1992 | 52.8 (261) |
Patient with an abnormal serum ALT | 79.6 (393) |
What percent of patients in your practice with hepatitis C have you referred for treatment? (N = 394)† | |
<25 | 23.6 (93) |
25–75 | 30.2 (119) |
>75 | 46.2 (182) |
Do you routinely offer to patients with hepatitis C (N = 397)† | |
Counseling about alcohol avoidance | 93.7 (371) |
Counseling about acetaminophen avoidance | 78.6 (312) |
Hepatitis A vaccination/testing | 84.4 (335) |
Hepatitis B vaccination/testing | 89.7 (356) |
HIV testing | 82.4 (327) |
* Minor differences in item responses (range, 487–490).
† Clinicians with hepatitis C patients in their practices.
ALT, alanine aminotransferase; HIV, human immunodeficiency virus.